Guidelines
for the Management of Hypoglycaemia
|
Reviewed by Jane Harding |
July
2004 |
Also see
guideline on investigation of severe hypoglycaemia
Click here for the Glucose calculator
Hypoglycaemia is important because:
- It is a common, readily diagnosed and readily
treated problem.
- If untreated, it may cause permanent brain
damage.
Definition
Serum glucose <2.6mM. This is based on
the following:
- Glucose levels within the ‘normal’ range
are not necessarily optimal.
- There is no physiological reason why brain
glucose requirements should differ between term and preterm infants, or
between the first and subsequent days of life.
- The aim is to define a level which is safe for
all babies, rather than is adequate for most.
- Altered electrophysiological measurements and
poor long-term neurological outcome have been reported in infants with
recurrent serum glucose levels <2.6mM.
Diagnosis
- Monitor at-risk infants
- All infants <10th centile or >95th
centile on customised centile
charts
- If customised centiles are not available,
all infants or birthweight < 2.5kg or
>4.5kg.
- Infants of diabetic mothers
- Stressed infants - i.e. those with birth
asphyxia, sepsis, haemolytic disease, respiratory distress or congenital
heart disease
- Infants with possible symptoms
- When to monitor
- Measure plasma glucose at 1-2 hours of
age, 4 hours, and then 4 hourly, preferably before feeds.
- How long to monitor
|
|
At
least 12 hours |
- Any recorded hypoglycaemia
|
At least 12 hours after last
low level |
Click here to
link to the flowchart for management of infants at risk of hypoglycaemia
Treatment
- All at risk infants (see above) should receive
milk feedings (either breastfeed or formula - maternal preference) or
intravenous dextrose as soon as feasible, and always within the first 2
hours of life.
- If glucose below 2.2mM on first testing (1-2
hours)
or 2.2-2.6mM after first 2 hours
feed immediately and recheck glucose
within 1 hour.
- If glucose below 2.2mM after first 2 hours
or below 2.6mM on more than 2 occasions
or feeds not tolerated
- start IV dextrose 10% at 60ml/kg/day (=
4.2mg/kg/min glucose)
- continue feeds if possible
- consider a bolus of 1-2ml/kg 10% dextrose IV
- recheck glucose within 1 hour
- Recurrent or persistent hypoglycaemia not
responding to above measures - increase IV dextrose concentration or volume
e.g. 12.5 or 15% dextrose and continue feeding if tolerated.
- For small-
or large-for-gestational age infants or infants of diabetic mothers on postnatal
wards, see separate guidelines.
Continuing Therapy
Continue to monitor glucoses while IV dextrose is
being gradually reduced. Rapid reductions in glucose infusion are likely to
cause rebound hypoglycaemia.
Persistent or severe hypoglycaemia (requiring
more than 10mg/kg/min of glucose or lasting longer than 1 week) may
require further investigation and management, e.g. with
glucagon,
diazoxide,
steroids or surgery.
Click here for the Glucose calculator
In an emergency,
particularly if there is difficulty in starting intravenous glucose infusion, glucagon
100 to 300ug/kg intramuscularly will stabilise blood glucose in most babies for
one to two hours. The dose can be repeated, but subsequent doses are much less
likely to be effective. (Glucagon mobilises glycogen stores. After the first
dose, stores will probably be depleted).
References
| 1 |
Koh THHG, Aynsley-Green A, Tarbit M, Eyre JA;
Neural dysfunction during hypoglycaemia. Arch Dis Child 1988; 63:
1353-1358. |
| 2 |
Koh THHG, Eyre JA, Aynsley-Green A; Neonatal
hypoglycaemia - the controversy regarding definition. Arch Dis Child 1988;
63:1386-1398 |
| 3 |
LaFranchi S; Hypoglycaemia of infancy and
childhood. Pediatric Clin N Amer 1987; 34(4): 961-80. |
| 4 |
Lubchenco LO, Bard H; Incidence of hypoglycemia
in newborn infants classified by birth weight and gestational age.
Pediatrics 1971; 47: 831-8. |
| 5 |
Lucas A, Morley R, Cole TJ; Adverse
neurodevelopmental outcome of moderate neonatal hypoglycaemia. Br Med J
1971; 297: 1304-8. |
| 6 |
Senior B, Sadeghi-Nejad A; Hypoglycemia: A
pathophysiologic approach. Acta Paediatr Scand Suppl 1989; 352: 1-27. |
| 7 |
Glaser
B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal
hyperinsulinism. Arch Dis Child Fetal Neonatal Ed 2000;
82:F79-F86. |
| 8 |
Shepherd
RM, Cosgrove KE, O'Brien RE, et al. Hyperinsulinism of infancy:
towards an understanding of unregulated insulin release. Arch Dis
Child Fetal Neonatal Ed 2000; 82:F87-F97. |
| 9 |
Aynsley-Green
A, Hussain K, Hall J, et al. Practical management of
hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 2000;
82:F98-F107. |
| 10 |
Rahier
J, Guiot Y, Sempoux C. Persistent hyperinsulinaemic hypoglycaemia
of infancy: a heterogenous syndrome unrelated to nesidioblastosis.
Arch Dis Child Fetal Neonatal Ed 2000; 82:F108-F112. |